18

rezultāts(-i)

Vārds(-i)
Publikācijas veids
Politikas joma
Jautājuma autors
Atslēgvārds
Datums

What if artificial intelligence in medical imaging could accelerate Covid-19 treatment?

21-12-2020

Thermal imaging cameras are currently being installed in office buildings, hospitals, shopping malls, schools and airports as a means of detecting people with fever-like symptoms. Given that these cameras are not necessarily designed to operate as medical devices, there are questions about their suitability in the context of the current pandemic. This note provides an overview of the use of thermal imaging empowered with artificial intelligence (AI) capabilities, its suitability in the context of ...

Thermal imaging cameras are currently being installed in office buildings, hospitals, shopping malls, schools and airports as a means of detecting people with fever-like symptoms. Given that these cameras are not necessarily designed to operate as medical devices, there are questions about their suitability in the context of the current pandemic. This note provides an overview of the use of thermal imaging empowered with artificial intelligence (AI) capabilities, its suitability in the context of the current pandemic and the core technical limitations of this technology. The main legal responses and ethical concerns related to the use of AI in the context of thermal imaging at entry points to identify and triage people who may have elevated temperatures are also examined.

Coronavirus testing: Contributing to efforts to stem the second wave

07-12-2020

The coronavirus (Covid-19) pandemic remains a major threat to public health in the European Union (EU). Testing is considered an essential aspect of the response to the pandemic. There are different types of coronavirus tests, each having its own merits and limitations. The timing of tests is also critical. Among the tests that detect current infection, (rapid) antigen tests have recently come to the fore. In view of a resurgence of coronavirus cases, the European Commission adopted on 28 October ...

The coronavirus (Covid-19) pandemic remains a major threat to public health in the European Union (EU). Testing is considered an essential aspect of the response to the pandemic. There are different types of coronavirus tests, each having its own merits and limitations. The timing of tests is also critical. Among the tests that detect current infection, (rapid) antigen tests have recently come to the fore. In view of a resurgence of coronavirus cases, the European Commission adopted on 28 October 2020 a recommendation for a common EU testing approach for Covid-19. It addresses key points linked to testing capacities and resources, as well as rapid antigen tests. This was followed on 18 November by a recommendation on the use of rapid antigen tests for the diagnosis of Covid-19, which provides guidance on how to select rapid antigen tests, when they are appropriate and who should perform them. It also calls for validation and mutual recognition of tests and their results. EU and international public health bodies, including the European Centre for Disease Prevention and Control and the World Health Organization, have given testing recommendations and outlined strategies and objectives. Several Member States have started to use rapid antigen tests in practice. Testing policies range from testing only people who both have symptoms and also meet specific criteria, to testing anyone with symptoms, to open public testing, including asymptomatic people. In a September 2020 resolution, the European Parliament called for the adoption and implementation of a common testing strategy under which test results would be recognised in all Member States. Since the outbreak of the pandemic, coronavirus testing has rapidly evolved and will continue to play an important role. New methods are emerging, including 'out of the box' options.

Outcome of the European Council video-conference of 29 October 2020

03-11-2020

On 29 October 2020, the Heads of State or Government met by video-conference to exchange information and coordinate efforts to defeat the pandemic, placing testing, tracing and vaccines at the centre of their strategy. EU leaders stressed the urgency of ensuring mutual recognition of rapid tests so as to enable the free movement of persons and to maintain open borders within the EU, as this is key to preserve a functional internal market. They condemned recent terrorist attacks in France and have ...

On 29 October 2020, the Heads of State or Government met by video-conference to exchange information and coordinate efforts to defeat the pandemic, placing testing, tracing and vaccines at the centre of their strategy. EU leaders stressed the urgency of ensuring mutual recognition of rapid tests so as to enable the free movement of persons and to maintain open borders within the EU, as this is key to preserve a functional internal market. They condemned recent terrorist attacks in France and have also discussed the tense situation in the Eastern Mediterranean.

What if AI could advance the science surrounding dementia?

10-06-2020

Artificial intelligence could help in the fight against dementia, a rapidly growing public health problem! Which AI applications in dementia diagnosis and treatment are already under way, and what are future directions and implications? What if, in the future, we could have access to human brains like Google maps? What if we could backup our minds and restore it when needed, such as in the case of getting dementia?

Artificial intelligence could help in the fight against dementia, a rapidly growing public health problem! Which AI applications in dementia diagnosis and treatment are already under way, and what are future directions and implications? What if, in the future, we could have access to human brains like Google maps? What if we could backup our minds and restore it when needed, such as in the case of getting dementia?

Brain: New approach to brain diseases

15-01-2019

This report summarises the presentations and discussion of the Workshop on “The Brain – A New Approach to Brain Diseases” held on 21 November, 2018 at the European Parliament. The purpose of the workshop was to highlight current and new approaches to the treatment of brain diseases, including diagnosis and rehabilitation. The panel of expert speakers addressed both clinical and policy issues and highlighted the need for dialogue and co-operation between scientists, industry and society.

This report summarises the presentations and discussion of the Workshop on “The Brain – A New Approach to Brain Diseases” held on 21 November, 2018 at the European Parliament. The purpose of the workshop was to highlight current and new approaches to the treatment of brain diseases, including diagnosis and rehabilitation. The panel of expert speakers addressed both clinical and policy issues and highlighted the need for dialogue and co-operation between scientists, industry and society.

Ārējais autors

Richard Twyman

Personalised Medicine - Current Status

30-11-2017

Personalised Medicine (PM - sometimes also termed as precision or stratified medicine) refers to the grouping of patients based on risk of disease, or response to therapy, using advanced diagnostic tests or techniques. The briefing gives an account of the initiatives taken at the EU to foster the advancement of this approach into daily practice.

Personalised Medicine (PM - sometimes also termed as precision or stratified medicine) refers to the grouping of patients based on risk of disease, or response to therapy, using advanced diagnostic tests or techniques. The briefing gives an account of the initiatives taken at the EU to foster the advancement of this approach into daily practice.

Autoimmune Diseases – Modern Diseases

23-10-2017

This report summarises the presentations and discussions of a workshop on “Autoimmune Diseases – Modern Diseases”, held at the European Parliament in Brussels on Monday 25 September 2017. The aim of the workshop was to provide background and technical information and advice to the members of the ENVI Committee on the latest findings and trends in the field of autoimmune diseases, specifically concerning treatment and prevention of such diseases. The current state of play of autoimmune diseases in ...

This report summarises the presentations and discussions of a workshop on “Autoimmune Diseases – Modern Diseases”, held at the European Parliament in Brussels on Monday 25 September 2017. The aim of the workshop was to provide background and technical information and advice to the members of the ENVI Committee on the latest findings and trends in the field of autoimmune diseases, specifically concerning treatment and prevention of such diseases. The current state of play of autoimmune diseases in Europe was highlighted during the first part of the workshop. Presentations focused on the public health prospective, and the possible causes of autoimmune diseases. The second part of the workshop focused on treatment and prevention of autoimmune diseases. This included presentations looking at the situation outside the US, and a focus on the lupus as a case study.

Ārējais autors

Mr Matteo MASCOLO Ms Alicia MCNEILL Ms Meena FERNANDES

Complementary and alternative therapies for patients today and tomorrow

23-10-2017

This report summarises the presentations and discussions of a workshop on “Complementary and Alternative Therapies for Patients Today and Tomorrow”, held at the European Parliament in Brussels on Monday 16 October 2017. The aim of the workshop was to provide background and technical information and advice to the members of the ENVI Committee on the latest findings and trends in the field of complementary and alternative therapies. The current state of play of complementary and alternative therapies ...

This report summarises the presentations and discussions of a workshop on “Complementary and Alternative Therapies for Patients Today and Tomorrow”, held at the European Parliament in Brussels on Monday 16 October 2017. The aim of the workshop was to provide background and technical information and advice to the members of the ENVI Committee on the latest findings and trends in the field of complementary and alternative therapies. The current state of play of complementary and alternative therapies in Europe was highlighted during the first part of the workshop. Presentations focused on CAM in practice and academic research. The second part of the workshop focused on the policy and legal framework in Europe and the integration of CAM into EU healthcare systems.

Ārējais autors

Alexandra SCHNEIDERS, Matteo MASCOLO, Alicia MCNEILL, Meena FERNANDES

What if your personal health tracker could save your life?

09-06-2017

Through advances in technology, big data has become a major asset and can open up numerous opportunities in all areas, but how can we use this in the context of health care and ensure it benefits everyone?

Through advances in technology, big data has become a major asset and can open up numerous opportunities in all areas, but how can we use this in the context of health care and ensure it benefits everyone?

Medical devices and in vitro diagnostic medical devices

29-03-2017

The current EU approval system for medical devices (MDs) and in vitro diagnostic medical devices (IVDs) is based on conformity assessment by 'notified bodies'. A number of scandals stressed the need to tighten the regulatory framework for such devices. The European Commission's proposals for regulations on MDs and IVDs, being discussed in parallel, are extensive and will repeal all existing rules. Votes in Parliament at second reading are expected during the April I plenary.

The current EU approval system for medical devices (MDs) and in vitro diagnostic medical devices (IVDs) is based on conformity assessment by 'notified bodies'. A number of scandals stressed the need to tighten the regulatory framework for such devices. The European Commission's proposals for regulations on MDs and IVDs, being discussed in parallel, are extensive and will repeal all existing rules. Votes in Parliament at second reading are expected during the April I plenary.

Gaidāmie notikumi

25-10-2021
European Gender Equality Week - October 25-28, 2021
Cits pasākums -
FEMM AFET DROI SEDE DEVE BUDG CONT ECON EMPL ITRE TRAN AGRI PECH CULT JURI PETI
25-10-2021
Capacity for proper expenditure controls of the increased budget of the MFF and NGEU
Uzklausīšana -
CONT
25-10-2021
Ninth meeting of the Joint Parliamentary Scrutiny Group on Europol, 25-26 October
Cits pasākums -
LIBE

Partneri